Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-041628
Filing Date
2017-06-23
Accepted
2017-06-23 16:02:10
Documents
1
Period of Report
2017-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3838
  Complete submission text file 0001209191-17-041628.txt   5463
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCORE BIOPHARMA, INC. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address
Ramaswamy Vivek (Reporting) CIK: 0001635075 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 17927583